Physician profile
David Linker
NPI 1083726178
$1,320.82
in general payments reported to CMS, 2019-2025
19 companies · $700 in 2025
The $700 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.47 · 2021: $83.72 · 2022: $159 · 2023: $171 · 2024: $168 · 2025: $700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,039.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $354.78 | 2024-2025 | |
| Medtronic, INC. | $170.98 | 2023 | Cobalt Dr Mri Surescan |
| Merck Sharp & Dohme LLC | $125.62 | 2021-2025 | Capvaxive, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $111.92 | 2024-2025 | |
| Pfizer INC. | $96.59 | 2021-2024 | |
| Amgen INC. | $63.40 | 2025 | Repatha, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $63.06 | 2025 | Entyvio |
| Novo Nordisk INC | $60.02 | 2024-2025 | Ozempic, Wegovy |
| Exact Sciences Corporation | $50.60 | 2025 | Cologuard Collection Kit |
| Atricure, INC. | $39.47 | 2019 | |
| Janssen Pharmaceuticals, INC | $29.82 | 2022 | |
| Sumitomo Pharma America, INC. | $25.03 | 2025 | Gemtesa |
| Exeltis, USA INC. | $22.78 | 2025 | Slynd |
| Glaxosmithkline, LLC. | $22.40 | 2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.63 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $18.45 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $17.34 | 2022 | |
| Inspire Medical Systems, INC. | $16.61 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals Lp | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Linker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.